
Japan · Research startup
Research and development of engineered platelets from iPS cells
Funding reportedLast round: Series D
Funding, as reported
What they build
Known for
biotechnology research
Built with from their website
Google MapsMicrosoft ExchangeFlexSliderMicrosoft 365 Apps & ServicesOpen GraphjQueryGoogle AnalyticsGoogle Maps (Non Paid Users)Microsoft Exchange OnlineNginx
Microsoft 365OutlookMicrosoft Email Providers
Add your raise, your deck and your story, and put Megakaryon Corporation in front of investors. Or tell us what we have wrong.